BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6162644)

  • 41. Androgen metabolism in the epithelial and stromal components of the human hyperplastic prostate.
    Habib FK; Tesdale AL; Chisholm GD; Busuttil A
    J Endocrinol; 1981 Oct; 91(1):23-32. PubMed ID: 6170712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intracellular localisation of 5alpha-dihydrotestosterone in human benign prostatic hypertrophy.
    Ghanadian R; Chisholm GD; Fotherby K
    Clin Chim Acta; 1976 Dec; 73(3):521-6. PubMed ID: 63340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Testosterone metabolism in prostatic adenoma and carcinoma tissue].
    Orestano F; Knapstein P
    Urologe A; 1972 Mar; 11(2):107-8. PubMed ID: 4112048
    [No Abstract]   [Full Text] [Related]  

  • 44. Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma.
    Snochowski M; Pousette A; Ekman P; Bression D; Andersson L; Högberg B; Gustafsson JA
    J Clin Endocrinol Metab; 1977 Nov; 45(5):920-30. PubMed ID: 72758
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparative C19-radiosteroid metabolism by MA 160 and HeLa cell lines.
    Ofner P; Vena RL; Barowsky NJ; Singer RM; Tashjian AH
    In Vitro; 1977 Jun; 13(6):378-88. PubMed ID: 69606
    [No Abstract]   [Full Text] [Related]  

  • 46. Binding of dihydrotestosterone, R 1881 and R 5020 in cytosols from normal, benign hypertrophic and cancerous human prostates.
    Nozumi K; Sato R; Ito H; Maruoka M; Shimazaki J
    Urol Int; 1981; 36(2):79-87. PubMed ID: 6169181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered androgen metabolism in metastatic prostate cancer.
    Kliman B; Prout GR; Maclaughlin RA; Daly JJ; Griffin PP
    J Urol; 1978 May; 119(5):623-6. PubMed ID: 77915
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dihydrotestosterone concentration in prostate cancer tissue as a predictor of tumor differentiation and hormonal dependency.
    Geller J; Albert J; de la Vega D; Loza D; Stoeltzing W
    Cancer Res; 1978 Nov; 38(11 Pt 2):4349-52. PubMed ID: 81107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of tamoxifen on the binding and metabolism of testosterone by human prostatic tissue and plasma in vitro.
    Habib FK; Rafati G; Robinson MR; Stitch SR
    J Endocrinol; 1979 Dec; 83(3):369-78. PubMed ID: 94084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro studies of testosterone and 5alpha-dihydrotestosterone binding in benign prostatic hypertrophy.
    Steins P; Krieg M; Hollmann HJ; Voigt KD
    Acta Endocrinol (Copenh); 1974 Apr; 75(4):773-84. PubMed ID: 4136809
    [No Abstract]   [Full Text] [Related]  

  • 51. A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate.
    Krieg M; Bartsch W; Janssen W; Voigt KD
    J Steroid Biochem; 1979 Jul; 11(1B):615-24. PubMed ID: 90754
    [No Abstract]   [Full Text] [Related]  

  • 52. Androgen receptors in benign and malignant prostatic tissue.
    Lakey WH; Bruchovsky N; Callaway T; Comeau T; Lieskovsky G; Rennie P; Shnitka T; Wilkin P
    Trans Am Assoc Genitourin Surg; 1979; 71():19-22. PubMed ID: 94714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal.
    Walsh PC; Hutchins GM; Ewing LL
    J Clin Invest; 1983 Nov; 72(5):1772-7. PubMed ID: 6195192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Supranormal nuclear content of 5 alpha-dihydrotestosterone in benign hyperplastic prostate of humans.
    Meikle AW; Collier ES; Middleton RG; Fang SM
    J Clin Endocrinol Metab; 1980 Oct; 51(4):945-7. PubMed ID: 6158523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Androgen concentrations and their receptors in the periurethral region are higher than those of the subcapsular zone in benign prostatic hyperplasia (BPH).
    Monti S; Di Silverio F; Toscano V; Martini C; Lanzara S; Varasano PA; Sciarra F
    J Androl; 1998; 19(4):428-33. PubMed ID: 9733145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The concentrations of the endogenous C19-steroids in hyperplastic prostatic tissue and the effect of finasteride treatment.
    Hill M; Petrik R; Hampl R; Stárka L
    Horm Metab Res; 1996 Oct; 28(10):562-4. PubMed ID: 8934217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Androgen metabolism within the lobes of rhesus monkey prostate.
    Ghanadian R; Smith CB
    Eur Urol; 1981; 7(2):89-91. PubMed ID: 7461009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Androgen metabolism in different target tissues.
    Martini L; Celotti F; Lechuga MJ; Melcangi RC; Motta M; Negri-Cesi P; Poletti A; Zoppi S
    Ann N Y Acad Sci; 1990; 595():184-98. PubMed ID: 1695827
    [No Abstract]   [Full Text] [Related]  

  • 59. Testosterone and dihydrotestosterone levels in the transition zone correlate with prostate volume.
    Pejčić T; Tosti T; Tešić Ž; Milković B; Dragičević D; Kozomara M; Čekerevac M; Džamić Z
    Prostate; 2017 Jul; 77(10):1082-1092. PubMed ID: 28594074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metal-androgen interrelationships in carcinoma and hyperplasia of the human prostate.
    Habib FK; Hammond GL; Lee IR; Dawson JB; Mason MK; Smith PH; Stitch SR
    J Endocrinol; 1976 Oct; 71(1):133-41. PubMed ID: 62007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.